Clinical Trial Update: 10% Lidocaine Spray for Intrauterine Device Insertion [Phase 4]

View source ↗

Summary

Clinical trial update for 10% lidocaine spray used during intrauterine device insertion shows completed Phase 4 study for contraception indications.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Contraception
• Intrauterine Device

Drugs mentioned

• 10% Lidocaine spray (lidocaine)

Snippet

Sponsor: Mahidol University | Conditions: Contraception, Intrauterine Device | Phase 4 | Status: COMPLETED